Details of the Drug | DrugMAP

General Information of Drug (ID: DMOAA5G)

Drug Name

Aroplatin

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C26H52N2O4Pt
Canonical SMILES: CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)N)N.[Pt+2]
InChI: 1S/2C10H20O2.C6H14N2.Pt/c2*1-10(2,3)8-6-4-5-7-9(11)12;7-5-3-1-2-4-6(5)8;/h2*4-8H2,1-3H3,(H,11,12);5-6H,1-4,7-8H2;/q;;;+2/p-2
InChIKey: PZAQDVNYNJBUTM-UHFFFAOYSA-L

Cross-matching ID

PubChem CID: 197256
TTD ID: D0A3NN

References

1	ClinicalTrials.gov (NCT00043199) A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies. U.S. National Institutes of Health.